Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Idiopathic Pulmonary Fibrosis, Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype, Systemic Sclerosis-associated Interstitial Lung Disease
Age: Adult
Dose: Oral – 150 mg
Frequency: twice daily
Note: Maximum: 300 mg daily
Indication: Locally advanced non-small cell lung carcinoma, Locally recurrent non-small cell lung carcinoma, Metastatic non-small cell lung carcinoma
Age: Adult
Condition: In combination with docetaxel
Dose: Oral – 200 mg
Frequency: twice daily on days 2 to 21 of a 21-day treatment cycle
Note: Maximum: 400 mg daily

Child Dose

Clinical InformationAdministration Information
Indication: Clinically significant, progressive fibrosing interstitial lung diseases and systemic sclerosis-associated interstitial lung disease
Age: 6 to 17 years
Dose: Oral – 50 mg
Frequency: Twice daily
Note: Route: Oral
Indication: Clinically significant, progressive fibrosing interstitial lung diseases and systemic sclerosis-associated interstitial lung disease
Age: 6 to 17 years
Dose: Oral – 75 mg
Frequency: Twice daily
Note: Route: Oral

Renal Dose

Clinical InformationAdministration Information
Condition: Mild-to-moderate renal impairment
Dose: Not specified
Note: No dosage adjustment required
Condition: Severe renal impairment (Creatinine Clearance less than 30 mL/min) or End Stage Renal Disease
Dose: Not specified
Note: Not studied
Administration
  • Take with food
  • Swallow capsules whole
Side Effect

Drug Interaction

Drug NameRisk Factors
Corticosteroids (Prednisone, Prednisolone, Methylprednisolone, Dexamethasone, Hydrocortisone), NSAIDs (Ibuprofen, Naproxen, Diclofenac, Celecoxib, Meloxicam, Indomethacin, Piroxicam, Ketorolac)
Increased risk of gastrointestinal adverse effect
Strong P-gp inhibitors (e.g. ketoconazole, erythromycin, ciclosporine)
Increased plasma concentration

Disease Interaction

Disease NameRisk Factors
No specific contraindications listed
Monitor for general drug reactions

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a cool and dry place, protected from light. Do not store above 25°C.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.